
Ophthalmologist

No OPD information available
Age-Related Macular Degeneration (ARMD)
Geographic Atrophy
Late-Onset Retinal Degeneration
Cerebral Hypoxia
Coats Disease
Diabetic Macular Edema (DME)
Retinitis Pigmentosa
Retinopathy Pigmentary Mental Retardation
Sorsby Fundus Dystrophy
Telangiectasia
Anhidrosis
Charles Bonnet Syndrome
Diabetic Retinopathy
Ganglion Cyst
Hajdu-Cheney Syndrome
Hereditary Sensory and Autonomic Neuropathy Type 2
Hereditary Sensory Neuropathy Type 1 (HSN1)
Obstructive Sleep Apnea
Papilledema
Peripheral Neuropathy
Retinal Artery Occlusion
Retinal Detachment
Shaken Baby Syndrome
Vitrectomy
Robyn H. Guymer is a female medical professional who specializes in helping patients with various eye conditions like Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Detachment. She also works with conditions like Cerebral Hypoxia and Peripheral Neuropathy.
Robyn H. Guymer uses special skills and treatments to care for her patients' eyes. She talks to patients in a friendly and clear way, making them feel comfortable and helping them understand their conditions better. Patients trust her because she is knowledgeable and caring.
To stay updated with the latest medical knowledge, Robyn H. Guymer reads new research and attends conferences. She also works with other medical professionals to share ideas and learn from each other. Her relationships with colleagues are strong, and they work together to provide the best care for patients.
Robyn H. Guymer's work has had a positive impact on many patients' lives. She has helped improve their vision and quality of life through her treatments and care. One of her notable publications is about the readiness of optometrists in managing geographic atrophy, showing her commitment to advancing eye care.
Although one of her clinical trials was terminated, Robyn H. Guymer continues to explore new treatments and techniques to help her patients. Her dedication to research and patient care makes her a respected and trusted medical professional in the field of ophthalmology.
Enrollment Status: Terminated
Published: April 15, 2025
Intervention Type: Device
Study Drug:
Study Phase: Not Applicable
